Overview
Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases
Status:
Recruiting
Recruiting
Trial end date:
2024-07-31
2024-07-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
Piezoelectric drived microneedling treats refractory skin disorders using hollow microneedles assisted by ultrasound. Mechanically, the injection of medicine by hollow microneedling could makes the distribution of medicine more evenly. And the addition of ultrasound technique improves the effectiveness of microneedling. Investigators plan to conduct a pilot study to investigate the efficacy of using piezoelectric drived microneedles in treating refractory skin diseases.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Xiangya Hospital of Central South UniversityTreatments:
Aminolevulinic Acid
Photosensitizing Agents
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:- Age over 16 years
- Diagnosed by 2 or more professional dermatologists
- Willing to underwent a new treatment modality
- Follow up is easy to conduct
Exclusion Criteria:
- Poor general condition
- Bleeding tendency
- Allergy to drug